용융 일렉트로라이팅(MEW) 시장 : 시장 예측 - 유형별, 재료별, 기술별, 용도별, 최종 사용자별, 지역별 분석(-2032년)

According to Stratistics MRC, the Global Melt Electrowriting Market is accounted for $19.59 billion in 2025 and is expected to reach $30.25 billion by 2032 growing at a CAGR of 6.4% during the forecast period. Melt Electrowriting (MEW) is an advanced additive manufacturing technique that integrates principles of electrospinning and melt extrusion to fabricate high-resolution, micron-scale 3D structures. In MEW, a heated polymer melt is extruded through a nozzle while a high-voltage electric field stretches and aligns the molten jet into ultrafine fibers (<10 µm diameter), enabling precise deposition as it solidifies. This method allows layer-by-layer construction of intricate geometries, such as porous networks or aligned fiber arrays, with submicron precision. MEW leverages biocompatible polymers like PCL and PLA to mimic natural tissues by tailoring fiber alignment and porosity.

Market Dynamics:

Driver:

Growing demand for biodegradable polymers

The increasing environmental concerns and regulatory push towards sustainable materials are boosting demand for biodegradable polymers in medical applications. Melt electrowriting allows the precise fabrication of biodegradable scaffolds, making it ideal for tissue engineering. These polymers degrade safely in the body, eliminating the need for secondary surgeries to remove implants. The shift toward eco-friendly solutions in biomedical engineering is opening new frontiers for MEW-based devices. This demand aligns with the broader goal of reducing environmental footprints while advancing healthcare solutions.

Restraint:

Technical complexity

The melt electrowriting process involves sophisticated equipment and highly controlled environmental conditions, posing barriers to adoption. Fine-tuning the interplay of parameters such as voltage, temperature, and polymer flow requires expert handling and infrastructure. Small-scale manufacturers or research labs often lack the resources or know-how to scale MEW processes efficiently. Moreover, any deviation from optimized conditions can significantly impact scaffold integrity and functionality. These complexities raise the operational costs and slow down widespread commercialization.

Opportunity:

Expansion in personalized medicine

Melt electrowriting supports the customization of micro-structured scaffolds tailored to individual patient anatomy. As precision medicine gains traction, the demand for patient-specific implants and drug delivery systems is rising. MEW enables the fabrication of fine architectures suited for cell growth and tissue regeneration, supporting regenerative therapies. It provides a flexible platform for integrating bioactive agents into tailored therapeutic scaffolds. With increased R&D in personalized healthcare, MEW technology stands to benefit from the ongoing shift towards individualized treatment modalities.

Threat:

Competition from established 3d printing technologies

Despite MEW's precision, it competes with mature 3D printing platforms like fused deposition modeling and stereolithography. These alternative technologies are more widely adopted and supported by robust supply chains and extensive user bases. Their versatility in materials and simpler operational requirements give them an edge in many biomedical applications. Continuous innovation in competing additive manufacturing techniques may reduce the perceived uniqueness of MEW. This competitive landscape may divert potential investment away from MEW towards more proven platforms.

Covid-19 Impact:

The pandemic initially disrupted R&D and manufacturing activities related to emerging fabrication technologies, including melt electrowriting. MEW-based scaffolds gained attention for their potential in creating models for respiratory research and regenerative applications. The pandemic also accelerated interest in decentralized, flexible manufacturing methods like MEW in healthcare. Long-term, the increased focus on healthcare resilience is expected to positively influence MEW development.

The scaffolds segment is expected to be the largest during the forecast period

The scaffolds segment is expected to account for the largest market share during the forecast period primarily due to the critical role scaffolds play in tissue engineering applications. Melt electrowriting (MEW) excels in fabricating highly organized and precise fibrous structures that closely mimic the natural extracellular matrix, which is essential for effective cell growth and tissue regeneration. As the healthcare industry continues to shift focus toward organ regeneration and advanced wound healing therapies, scaffold-based solutions are expected to remain at the forefront of MEW applications.

The polymers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the polymer segment is predicted to witness the highest growth rate driven by ongoing innovations in polymer science. The increasing use of biocompatible and biodegradable polymers in MEW has expanded the material options available for medical and pharmaceutical applications. These polymeric materials offer versatile functionalities, making them ideal for use in drug delivery systems and regenerative therapies. As a result, the ability to tailor polymer properties to meet specific therapeutic needs is expected to be a key factor propelling the growth of this segment in the coming years.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to growing investments in biomedical research and infrastructure. Countries like China, Japan, and South Korea are advancing rapidly in additive manufacturing and healthcare innovation. The region benefits from a strong manufacturing base and increasing government support for biotech industries. Academic collaborations and rising medical device startups are further catalyzing growth. The surge in demand for localized, cost-effective healthcare solutions also enhances MEW's adoption in this region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR due to its advanced research infrastructure and strong presence of key market players. The region benefits from significant investments in biomedical research, tissue engineering, and additive manufacturing technologies. Additionally, high adoption rates of advanced healthcare technologies and growing demand for customized medical solutions, such as tissue scaffolds and drug delivery systems, are fueling market expansion.

Key players in the market

Some of the key players in Melt Electrowriting Market include 3D Biotek, Pfizer, Avery Dennison, Biomedical Structures, Cambus Medical, Celanese, Confluent Medical Technologies, DSM Biomedical, Evonik, Freudenberg Medical, Huizhou Foryou Medical Devices, Jiangsu Hengtong Medical Equipment, Jiangsu Tongxiang Medical Equipment, Kuraray and Medtronic.

Key Developments:

In February 2025, Evonik introduced an enhanced version of its VESTAKEEP(R) PEEK filament for melt electrowriting applications at a European biomaterials conference. This updated material offers improved thermal stability and biocompatibility, targeting advanced tissue scaffolds for orthopedic implants.

In January 2025, Medtronic expanded its collaboration with the University of Wollongong, announcing a pilot program to integrate melt electrowritten scaffolds into next-generation neurovascular stents. This builds on their 2023 efforts, with initial clinical trials slated for late 2025.

In January 2025, DSM Biomedical launched a new bioresorbable polymer tailored for melt electrowriting, designed to degrade at controlled rates for soft tissue regeneration. The product targets applications in wound healing and is being tested with select medical device manufacturers.

Types Covered:

• Scaffolds
• Poly
• Other Types

Materials Covered:

• Polymers
• Ceramics
• Composites
• Other Materials

Technologies Covered:

• Traditional Extrusion Techniques
• 3D Printing Technologies
• Other Technologies

Applications Covered:

• Tissue Engineering
• Drug Delivery
• Filtration
• Other Applications

End Users Covered:

• Healthcare
• Electronics
• Automotive
• Aerospace
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.5 Technology Analysis
• 3.5 Application Analysis
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Melt Electrowriting Market, By Type

• 5.1 Introduction
• 5.2 Scaffolds
• 5.3 Poly
• 5.4 Other Types

6 Global Melt Electrowriting Market, By Material

• 6.1 Introduction
• 6.2 Polymers
• 6.3 Ceramics
• 6.4 Composites
• 6.5 Other Materials

7 Global Melt Electrowriting Market, By Technology

• 7.1 Introduction
• 7.2 Traditional Extrusion Techniques
• 7.3 3D Printing Technologies
• 7.4 Other Technologies

8 Global Melt Electrowriting Market, By Application

• 8.1 Introduction
• 8.2 Tissue Engineering
• 8.3 Drug Delivery
• 8.4 Filtration
• 8.5 Other Applications

9 Global Melt Electrowriting Market, By End User

• 9.1 Introduction
• 9.2 Healthcare
• 9.3 Electronics
• 9.4 Automotive
• 9.5 Aerospace
• 9.6 Other End Users

10 Global Melt Electrowriting Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 3D Biotek
• 12.2 Pfizer
• 12.3 Avery Dennison
• 12.4 Biomedical Structures
• 12.5 Cambus Medical
• 12.6 Celanese
• 12.7 Confluent Medical Technologies
• 12.8 DSM Biomedical
• 12.9 Evonik
• 12.10 Freudenberg Medical
• 12.11 Huizhou Foryou Medical Devices
• 12.12 Jiangsu Hengtong Medical Equipment
• 12.13 Kuraray
• 12.14 Medtronic